我要投票 爱威在医疗器械行业中的票数:99
· 外 推 电 报 ·
2025-01-19 08:26:48 星期日

【爱威是哪个国家的品牌?】

爱威是什么牌子?「爱威」是 爱威科技股份有限公司 旗下著名品牌。该品牌发源于湖南省长沙市,由创始人丁 * 文在2000年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

爱威科技股份有限公司成立于2000年3月16日,总部位于湖南长沙高新技术产业开发区,是一家按照现代企业制度组建而成的专业从事医疗器械、实验仪器、体外诊断试剂与耗材、电子产品、远程医疗网络、计算机软件、自动控制设备、医疗辅助设备等产品的研究、开发、生产、销售及相关技术服务的现代企业。公司基于“创新驱动发展”战略,专注于临床医疗检验设备、体外诊断试剂及医用耗材的研发和产业化,自主创新研发的“医学显微镜形态学检验自动化”等多项关键共性技术处于国际出色地位。公司已成长为国内具国际竞争力的高性能医疗检验设备提供商,并于2015年2月在新三板挂牌上市(股票名称:爱威科技,股票代码:831895)。

爱威科技在国内外设立了两家全资子公司,其中湖南爱威医疗科技有限公司位于长沙岳麓区岳麓科技产业园,占地67亩,已建成高性能医疗器械及体外诊断试剂耗材研发与生产基地超过5万平方米;美国全资子公司AVETECH INC.(爱威科技(美国)有限公司)于2015年在美国马里兰州盖塞斯堡注册成立。

公司聚集了一批多学科领域的博士、硕士、本科等技术型人才,并承担了医学显微镜检验自动化湖南省工程研究中心等省部级工程研究中心的建设。公司专注于智能医学检验关键技术和相关医疗设备研发,尤其在自动显微镜形态学检验领域,形成了以国际前沿的“机器视觉技术”和“智能显微镜形态学检验技术”为核心的重大科技成果,实现了临床尿液、血液、粪便、体液等标本中有形病理成分显微图像高速可视,智能识别分类和定量计数,终结了显微镜检查只能依靠人工完成的历史。目前公司在全国30个省级行政区设立了办事机构,产品在国内装机用户已超过4000家;在国际上,产品已出口到欧洲、美洲、亚洲等国家和地区。

公司将继续秉承“科技服务健康”的核心理念,以“创造成果,实现价值,共同发展”为经营宗旨,通过自主研发和整合国际国内出色技术,采用专业的生产工艺,专注于医疗器械、实验仪器和体外诊断试剂、耗材等的研究、开发和产业化,使公司成长为国际、国内受人尊重的高性能医疗器械研发、制造和医疗健康服务行业的标杆企业,为实现“让老百姓都能享受现代医疗健康服务”的美好愿景而努力奋斗。


英文翻译:Founded on March 16, 2000 and headquartered in Changsha hi tech Industrial Development Zone, Hunan Province, AVIC Technology Co., Ltd. is a company established in accordance with the modern enterprise system, specializing in the research and development of medical devices, experimental instruments, in vitro diagnostic reagents and consumables, electronic products, telemedicine network, computer software, automatic control equipment, medical auxiliary equipment and other products A modern enterprise engaged in development, production, sales and related technical services. Based on the strategy of "innovation driven development", the company focuses on the R & D and industrialization of clinical medical testing equipment, in vitro diagnostic reagents and medical consumables, and many key generic technologies such as "medical microscope Morphology Test Automation" independently innovated and developed are in an outstanding position in the world. The company has grown into a high-performance medical inspection equipment provider with international competitiveness, and was listed on the new third board in February 2015 (Stock Name: AVIC technology, stock code: 831895). AVIC technology has set up two wholly-owned subsidiaries at home and abroad, of which Hunan AVIC Medical Technology Co., Ltd. is located in Yuelu science and Technology Industrial Park, Yuelu District, Changsha, covering an area of 67 mu, and has built a research and development and production base of high-performance medical devices and in vitro diagnostic reagent consumables of more than 50000 square meters; avetech Inc., a wholly-owned subsidiary of AVIC Technology (America) Co., Ltd., was in the United States in 2015 Gaicesburg, Maryland. The company has gathered a number of multi-disciplinary technical talents such as doctors, masters and undergraduates, and has undertaken the construction of provincial and ministerial engineering research centers such as Hunan Engineering Research Center of medical microscope inspection automation. The company focuses on the research and development of key technologies of intelligent medical examination and related medical equipment, especially in the field of automatic microscopic morphology examination. It has formed major scientific and technological achievements with the international cutting-edge "machine vision technology" and "intelligent microscopic morphology examination technology" as the core, realizing the high-speed microscopic image of tangible pathological components in clinical urine, blood, feces, body fluids and other specimens Visual, intelligent recognition, classification and quantitative counting have ended the history that microscopy can only be done by human. At present, the company has set up offices in 30 provincial administrative regions, with more than 4000 domestic installed users. Internationally, the products have been exported to Europe, America, Asia and other countries and regions. The company will continue to adhere to the core concept of "science and technology serve health", with the business purpose of "creating achievements, realizing value and common development", through independent research and development and integration of international and domestic excellent technology, adopting professional production technology, focusing on the research, development and industrialization of medical devices, experimental instruments, in vitro diagnostic reagents, consumables, etc., so that the company can grow into an international and national company The high-performance medical device R & D, manufacturing and medical and health service industry benchmarking enterprises that are respected by the people strive to realize the good vision of "let people enjoy modern medical and health services".

本文链接: https://www.waitui.com/brand/f8296e44c.html 联系电话:400-860-0071,0731-88925460

千城特选小程序码

7×24h 快讯

姚伟雄先生将不再担任安踏集团时尚运动品牌群 CEO 职务,江艳女士将接任时尚运动品牌群 CEO

36氪获悉,因已届退休年龄,姚伟雄先生将不再担任安踏集团时尚运动品牌群 CEO 职务,未来他将继续担任集团副总裁,负责集团时尚产业项目的日常管理与运营。自 2010 年起,姚伟雄先生一直负责 FILA品牌大中华地区的业务,带领团队将 FILA 打造成中国时尚运动赛道的标杆品牌,跻身中国前五大运动品牌之列。集团高度肯定姚伟雄先生为公司和行业所做出的杰出贡献,并祝愿他在新的岗位继续发挥更多的才能。 江艳女士将接任时尚运动品牌群 CEO,全面负责时尚运动品牌群的经营管理,继续推动 FILA 夯实“高端时尚运动品牌“的心智定位,实现品牌驱动的业务增长。江艳女士是集团长期培养的年轻梯队干部,拥有丰富的品牌管理经验,曾先后操盘 ANTA KIDS FILA FUSION 的品牌管理工作,实现了两个品牌在细分市场的领先心智。她将领导 FILA 进一步拓展在年轻人群中的影响力,为消费者创造更多的价值。

27分钟前

国新创投基金启航 首期规模100亿元

中国国新联合部分中央企业、地方国资1月18日在京共同举行国新创投基金合作签约仪式。国新创投基金出资合作单位有中国五矿、中国钢研、中国建材、中国有研、中国电气装备、杭州资本、兴湘集团等,首期规模100亿元,存续期15年,同时将启动杭州、湖南、西安等一批子基金,通过母子基金放大方式,围绕“国家所需、创新所要、基金所能”,坚持投早、投小、投长期、投硬科技,为科技强国建设和新质生产力培育贡献力量。(财联社)

27分钟前

新凤鸣入选首批国家工信部“卓越级智能工厂”

近日,新凤鸣集团“化纤全产业链协同智能工厂”入选国家“卓越级智能工厂(第一批)项目名单(共235家)”,是浙江省上榜的13家企业之一,也是化纤行业唯一上榜企业。(证券时报)

27分钟前

先锋集团将支付1.06亿美元以和解美国SEC指控

美国证券交易委员会(SEC)当地时间1月17日在一份新闻稿中指出,先锋集团(The Vanguard Group, Inc.)将支付1.0641亿美元,以和解有关其对资本利得分配和税收影响的误导性陈述的指控,这些误导性陈述影响了在应纳税账户中持有先锋投资者目标退休基金(Investor TRFs)的零售投资者。和解金额将分配给受影响的投资者。(财联社)

27分钟前

今年首家!千亿公募换帅

2025年开年,公募基金行业迎来今年首次基金公司换帅。1月18日,兴银基金发布基金行业高级管理人员变更公告,公告显示,易勇新任兴银基金总经理,同时,董事长吴若曼不再代为履行总经理职务。 Wind数据显示,截至2024年9月30日,兴银基金旗下公募产品数量54只,公募管理规模为1067.32亿元。根据银河证券数据显示,近二年固收排名40/129,近三年排名32/119,近五年排名9/93,在权益方面,兴银基金近两年排名进入前10%(12/124)。(券商中国)

27分钟前

本页详细列出关于伟思VISHEE的品牌信息,含品牌所属公司介绍,伟思VISHEE所处行业的品牌地位及优势。
咨询